| Year |
Citation |
Score |
| 2017 |
Wang DD, Yu Y, Kassir N, Zhu M, Hanley WD, Earp JC, Chow AT, Gupta M, Hu C. The Utility of a Population Approach in Drug-Drug Interaction Assessments: A Simulation Evaluation. Journal of Clinical Pharmacology. PMID 28513856 DOI: 10.1002/jcph.921 |
0.577 |
|
| 2015 |
Lon HK, DuBois DC, Earp JC, Almon RR, Jusko WJ. Modeling effects of dexamethasone on disease progression of bone mineral density in collagen-induced arthritic rats. Pharmacology Research & Perspectives. 3: e00169. PMID 26516581 DOI: 10.1002/Prp2.169 |
0.582 |
|
| 2014 |
Chow AT, Earp JC, Gupta M, Hanley W, Hu C, Wang DD, Zajic S, Zhu M. Utility of population pharmacokinetic modeling in the assessment of therapeutic protein-drug interactions. Journal of Clinical Pharmacology. 54: 593-601. PMID 24272952 DOI: 10.1002/jcph.240 |
0.591 |
|
| 2013 |
Kenny JR, Liu MM, Chow AT, Earp JC, Evers R, Slatter JG, Wang DD, Zhang L, Zhou H. Therapeutic protein drug-drug interactions: navigating the knowledge gaps-highlights from the 2012 AAPS NBC Roundtable and IQ Consortium/FDA workshop. The Aaps Journal. 15: 933-40. PMID 23794076 DOI: 10.1208/s12248-013-9495-1 |
0.595 |
|
| 2010 |
Ghoshal S, Rao I, Earp JC, Jusko WJ, Wetzler M. Down-regulation of heat shock protein 70 improves arsenic trioxide and 17-DMAG effects on constitutive signal transducer and activator of transcription 3 activity. Cancer Chemotherapy and Pharmacology. 66: 681-9. PMID 20035426 DOI: 10.1007/S00280-009-1210-7 |
0.388 |
|
| 2009 |
Earp JC, Dubois DC, Almon RR, Jusko WJ. Quantitative dynamic models of arthritis progression in the rat. Pharmaceutical Research. 26: 196-203. PMID 18758921 DOI: 10.1007/S11095-008-9711-3 |
0.481 |
|
| 2008 |
Earp JC, Pyszczynski NA, Molano DS, Jusko WJ. Pharmacokinetics of dexamethasone in a rat model of rheumatoid arthritis. Biopharmaceutics & Drug Disposition. 29: 366-72. PMID 18613033 DOI: 10.1002/Bdd.626 |
0.503 |
|
| 2008 |
Earp JC, Dubois DC, Molano DS, Pyszczynski NA, Keller CE, Almon RR, Jusko WJ. Modeling corticosteroid effects in a rat model of rheumatoid arthritis I: mechanistic disease progression model for the time course of collagen-induced arthritis in Lewis rats. The Journal of Pharmacology and Experimental Therapeutics. 326: 532-45. PMID 18448865 DOI: 10.1124/Jpet.108.137372 |
0.559 |
|
| 2008 |
Earp JC, Dubois DC, Molano DS, Pyszczynski NA, Almon RR, Jusko WJ. Modeling corticosteroid effects in a rat model of rheumatoid arthritis II: mechanistic pharmacodynamic model for dexamethasone effects in Lewis rats with collagen-induced arthritis. The Journal of Pharmacology and Experimental Therapeutics. 326: 546-54. PMID 18448864 DOI: 10.1124/Jpet.108.137414 |
0.581 |
|
| 2007 |
Wetzler M, Earp JC, Brady MT, Keng MK, Jusko WJ. Synergism between arsenic trioxide and heat shock protein 90 inhibitors on signal transducer and activator of transcription protein 3 activity--pharmacodynamic drug-drug interaction modeling. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 2261-70. PMID 17404111 DOI: 10.1158/1078-0432.Ccr-06-2468 |
0.419 |
|
| 2006 |
Drake AS, Michael BT, Wang XH, Sait SJ, Earp JC, Jusko WJ, Ferrone S, Wang ES, Wetzler M. The Effects of Anti-High Molecular Weight-Melanoma Associated Antigen (HMW-MAA) Monoclonal Antibodies (mAb) Against 11q23 Positive Acute Leukemia Cells. Blood. 108: 4550-4550. DOI: 10.1182/Blood.V108.11.4550.4550 |
0.441 |
|
| 2004 |
Earp J, Krzyzanski W, Chakraborty A, Zamacona MK, Jusko WJ. Assessment of drug interactions relevant to pharmacodynamic indirect response models. Journal of Pharmacokinetics and Pharmacodynamics. 31: 345-80. PMID 15669772 DOI: 10.1007/S10928-004-8319-4 |
0.621 |
|
| Show low-probability matches. |